Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POTA: Preoperative Octreotide in Acromegaly
NCT00521300Phase 4Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Sep 1999
- Primary completion
- Jun 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Octreotide long-acting injection in acromegaly, sponsored by St. Olavs University Hospital. Started Sep 1999; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00521300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521300.